Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL)

Vascular Biogenics Ltd. operating as VBL Therapeutics · 2017
ClinicalTrials.gov · Datasets · License: Public Domain · 2017
Open Source ↗
ovariancancerpaclitaxel
recurrent platinum resistant ovarian cancer, recurrent ovarian cancer, platinum resistant ovarian cancer, ovarian cancer, ovarian carcinoma, epithelial ovarian cancer, paclitaxel, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 849794
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.